Non-invasive decision support for NSCLC treatment using PET/CT radiomics

Non-invasive decision support for NSCLC treatment using PET/CT radiomics

EGFR mutations are common in non-small cell lung cancer and patients with these mutations are treated with tyrosine kinase inhibitors. Here, the authors show that EGFR mutation status can be predicted from 18F-FDG-PET/CT images, which may enable the stratification of patients for treatment.

Bibliographic Details
Main Authors: Wei Mu, Lei Jiang, JianYuan Zhang, Yu Shi, Jhanelle E. Gray, Ilke Tunali, Chao Gao, Yingying Sun, Jie Tian, Xinming Zhao, Xilin Sun, Robert J. Gillies, Matthew B. Schabath
Format: Article
Language:English
Published: Nature Portfolio 2020-10-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-19116-x

Internet

https://doi.org/10.1038/s41467-020-19116-x

Similar Items